Kim K - Search Results

1

Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing.

Zolekar A, Kim K, Lee JC, Han J, Duarte JD, Galanter WL, Cavallari LH, Nutescu EA. Zolekar A, et al. Among authors: kim k. Pharmacogenomics. 2022 Jan;23(2):85-95. doi: 10.2217/pgs-2021-0109. Epub 2022 Jan 10. Pharmacogenomics. 2022. PMID: 35001645 Free article.

2

Cost-Effectiveness of Strategies to Personalize the Selection of P2Y₁₂ Inhibitors in Patients with Acute Coronary Syndrome.

Kim K, Touchette DR, Cavallari LH, Ardati AK, DiDomenico RJ. Kim K, et al. Cardiovasc Drugs Ther. 2019 Oct;33(5):533-546. doi: 10.1007/s10557-019-06896-8. Cardiovasc Drugs Ther. 2019. PMID: 31367811

3

Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations.

Kim K, Duarte JD, Galanter WL, Han J, Lee JC, Cavallari LH, Nutescu EA. Kim K, et al. Pharmacogenomics. 2023 Apr;24(6):303-314. doi: 10.2217/pgs-2023-0014. Epub 2023 May 11. Pharmacogenomics. 2023. PMID: 37166395

4

Socioecologic Factors and Racial Differences in Breast Cancer Multigene Prognostic Scores in US Women.

Parab AZ, Kong A, Lee TA, Kim K, Nutescu EA, Malecki KC, Hoskins KF, Calip GS. Parab AZ, et al. Among authors: kim k. JAMA Netw Open. 2024 Apr 1;7(4):e244862. doi: 10.1001/jamanetworkopen.2024.4862. JAMA Netw Open. 2024. PMID: 38568689 Free PMC article.

5

Providers' utilization and perceptions of warfarin dosing algorithms.

Gardner T, Vazquez SR, Kim K, Jones AE, Witt DM. Gardner T, et al. Among authors: kim k. Thromb Res. 2019 Nov;183:4-12. doi: 10.1016/j.thromres.2019.09.002. Epub 2019 Sep 4. Thromb Res. 2019. PMID: 31505378

6

Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US.

Kim K, Craft LK. Kim K, et al. BMJ Open. 2022 Jun 15;12(6):e057658. doi: 10.1136/bmjopen-2021-057658. BMJ Open. 2022. PMID: 35705340 Free PMC article.

7

Positive Association between Peri-Surgical Opioid Exposure and Post-Discharge Opioid-Related Outcomes.

Kim K, Biskupiak JE, Babin JL, Ilham S. Kim K, et al. Healthcare (Basel). 2022 Dec 30;11(1):115. doi: 10.3390/healthcare11010115. Healthcare (Basel). 2022. PMID: 36611576 Free PMC article.

8

Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome.

Kim K, Lee TA, Ardati AK, DiDomenico RJ, Touchette DR, Walton SM. Kim K, et al. Pharmacotherapy. 2017 Aug;37(8):877-887. doi: 10.1002/phar.1961. Epub 2017 Jul 18. Pharmacotherapy. 2017. PMID: 28555946

9

Comparison of 6-Month Costs Between Oral Antiplatelet Agents Following Acute Coronary Syndrome.

Kim K, Lee TA, Touchette DR, DiDomenico RJ, Ardati AK, Walton SM. Kim K, et al. J Manag Care Spec Pharm. 2018 Aug;24(8):800-812. doi: 10.18553/jmcp.2018.24.8.800. J Manag Care Spec Pharm. 2018. PMID: 30058986 Free PMC article.

10

Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.

Kim K, Magness JW, Nelson R, Baron V, Brixner DI. Kim K, et al. J Manag Care Spec Pharm. 2018 Dec;24(12):1250-1259. doi: 10.18553/jmcp.2018.24.12.1250. J Manag Care Spec Pharm. 2018. PMID: 30479202 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,690 results

Search Page

Filters